Amianto, Federico
Arletti, Luca
Vesco, Serena
Davico, Chiara
Vitiello, Benedetto
Funding for this research was provided by:
UniversitĂ degli Studi di Torino
Article History
Received: 21 October 2022
Accepted: 8 May 2023
First Online: 25 May 2023
Declarations
:
: The authors declare no competing interests.
: The study was conducted according to the Helsinki declaration as revised in Edinburgh in 2000. All participants and their parents gave their written informed consent for participation in clinical research at intake in the outpatient service. All contacted participants who agreed for participation in the study gave their written informed consent at follow-up. The Intercompany Review Board of Torino (CEI) approved this study with the protocol number 36931.
: Not applicable. The manuscript does not contain any individual person’s data in any form (including individual details, images or videos).
: The authors transfer the copyright to Springer Nature.
: In the last 3 years, BV was a paid consultant for Medice, Menarini, Alkermes, and Angelini Pharmaceuticals; he received research funds from the Italian Ministry of University and Research, the Italian Autism Foundation, and the Credito Italiano di Torino Foundation. CD has received consultant fees from Roche and Lundbeck and also research funds from the Italian Ministry of University and Research and from the Italian Autism Foundation. LA received a consultant fee from Roche. FA and SV declare no financial disclosure or conflict of interest with the present paper.